Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue - OtherShares Issued
Ratios

Perspective Therapeutics (CATX) Leases (2019 - 2025)

Perspective Therapeutics (CATX) has disclosed Leases for 9 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Leases fell 32.28% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 32.28% year-over-year, with the annual reading at $1.5 million for FY2025, 32.28% down from the prior year.
  • Leases hit $1.5 million in Q4 2025 for Perspective Therapeutics, down from $1.5 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $2.4 million in Q3 2024 to a low of $309000.0 in Q1 2023.
  • Historically, Leases has averaged $1.2 million across 5 years, with a median of $830000.0 in 2021.
  • Biggest YoY gain for Leases was 243.6% in 2023; the steepest drop was 46.45% in 2023.
  • Year by year, Leases stood at $642000.0 in 2021, then tumbled by 30.69% to $445000.0 in 2022, then skyrocketed by 67.87% to $747000.0 in 2023, then soared by 196.52% to $2.2 million in 2024, then tumbled by 32.28% to $1.5 million in 2025.
  • Business Quant data shows Leases for CATX at $1.5 million in Q4 2025, $1.5 million in Q3 2025, and $1.8 million in Q2 2025.